0001209191-23-020397.txt : 20230321
0001209191-23-020397.hdr.sgml : 20230321
20230321191637
ACCESSION NUMBER: 0001209191-23-020397
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230317
FILED AS OF DATE: 20230321
DATE AS OF CHANGE: 20230321
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PHILIPS CRAIG W.
CENTRAL INDEX KEY: 0001441383
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37695
FILM NUMBER: 23750901
MAIL ADDRESS:
STREET 1: C/O KINETA, INC.
STREET 2: 219 TERRY AVE. N., SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98109
FORMER NAME:
FORMER CONFORMED NAME: PHILIPS CRAIG
DATE OF NAME CHANGE: 20080729
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KINETA, INC./DE
CENTRAL INDEX KEY: 0001445283
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 219 TERRY AVE. N.
STREET 2: SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: (206) 378-0400
MAIL ADDRESS:
STREET 1: 219 TERRY AVE. N.
STREET 2: SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98109
FORMER COMPANY:
FORMER CONFORMED NAME: YUMANITY THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20201223
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20140813
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS INC
DATE OF NAME CHANGE: 20080916
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-03-17
0
0001445283
KINETA, INC./DE
KA
0001441383
PHILIPS CRAIG W.
C/O KINETA, INC.
219 TERRY AVE. N., SUITE 300
SEATTLE
WA
98109
0
1
0
0
President
0
Common Stock
2023-03-17
4
S
0
1196
4.9352
D
67884
D
Common Stock
2023-03-17
4
S
0
34
5.23
D
67850
D
Common Stock
2023-03-17
4
S
0
1
5.25
D
67849
D
Common Stock
2023-03-20
4
S
0
872
3.2868
D
66977
D
Common Stock
33272
I
By Whetstone Ventures, LLC
Shares of the Issuer's Common Stock were sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's Common Stock in connection with the settlement of the vested portion of restricted stock units.
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.22 to $5.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.20 to $3.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The Reporting Person is a member manager of Whetstone Ventures, LLC ("Whetstone") and shares voting and dispositive power over the shares held by Whetstone.
/s/ Pauline Kenny, as Attorney-in-Fact
2023-03-21